Ország: Egyesült Királyság
Nyelv: angol
Forrás: VMD (Veterinary Medicines Directorate)
Lufenuron
Elanco Europe Ltd
QP53BC01
Lufenuron
Suspension for injection
POM-V - Prescription Only Medicine – Veterinarian
Cats
Insect Growth Regulator
Expired
1997-12-05
Revised: March 2016 AN: 01695/2015 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT PROGRAM 40 mg Suspension for injection for cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Lufenuron (INN), 40 mg per syringe (0.4 ml of a 10% suspension) EXCIPIENT(S): Povidone 12 in an aqueous vehicle. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Suspension for injection White to yellow suspension in a pre-filled single-dose syringe for injection. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cats and weaned kittens less than 4 kg bodyweight. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES The product is intended for the prevention of flea multiplication in cats by inhibiting the development of flea eggs to adults for 6 months. The product is effective against eggs and larval stages of fleas. Effective blood levels of Lufenuron are attained within 21 days. 4.3 CONTRAINDICATIONS Do not use in dogs. The excipient Polyvinylpyrrolidone (Povidone) is a potent histamine releasing substance in dogs. A severe reaction may occur in dogs that is not observed in cats. 4.4 SPECIAL WARNINGS If cats have flea infestation at the start of treatment, the use of a flea adulticide is recommended. It is essential that all cats (except for unweaned kittens) living in a household are treated with the product to stop flea infestation. Dogs in the same household should be treated as recommended by the prescribing veterinary surgeon. Revised: March 2016 AN: 01695/2015 Page 2 of 5 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS The injection should be carried out under aseptic conditions. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS In the case of self-inoculation a local reaction may occur. In such circumstances seek medical advice. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) Adverse reactions are very rarely reported. On very rare occasions injection with the product may cause Olvassa el a teljes dokumentumot